anti-HLA antibodies,
Showing 9976 - 10000 of >10,000
Subclinical Hypothyroidism and Outcome of Pregnancy
Completed
- Abortion, Spontaneous
- +2 more
-
Naestved, DenmarkNaestved Hospital
Mar 17, 2020
ASAS Criteria in West Indian Patients Seen in Consultation of
Active, not recruiting
- Spondyloarthritis
- Evaluation of ASAS criteria
-
Fort-de-France, MartiniqueCHU de Martinique
Mar 29, 2021
Parkinson's Disease Severe Hypertension During Motor OFFs.
Suspended
- Parkinson Disease
- +2 more
- No Intervention
-
Portland, OregonVA Portland Health Care System
Nov 15, 2021
Hodgkin Lymphoma Trial in Saint Petersburg, Irkutsk (Nivolumab, Ifosfamide, Carboplatin)
Recruiting
- Hodgkin Lymphoma
- Nivolumab
- +3 more
-
Saint Petersburg, Pesochny, Russian Federation
- +2 more
Jul 19, 2021
Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)
Recruiting
- Colorectal Cancer
- Immunotherapy
- mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
-
Guangzhou, Guangdong, ChinaSun Yatsen University
May 19, 2021
Sickle Cell Disease Trial in Chicago (procedure, drug, radiation)
Terminated
- Sickle Cell Disease
- Haploidentical Transplant
- +4 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Aug 22, 2019
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,
Completed
- Advanced Malignant Neoplasm
- +3 more
- Anakinra
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 24, 2021
COVID-19, SARS-CoV 2 Trial in United States (COVID-19 Convalescent Plasma)
No longer available
- COVID-19
- SARS-CoV 2
- COVID-19 Convalescent Plasma
-
Aurora, Colorado
- +5 more
Aug 26, 2020
Improvement in Endothelial Dysfunction After Initiation of
Completed
- Atrial Fibrillation
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center - Presbyterian Universit
Jan 11, 2021
COVID-19 Trial in Hackensack (Convalescent Plasma)
Active, not recruiting
- COVID-19
- Convalescent Plasma
-
Hackensack, New JerseyHackensack University Medical Center
May 3, 2022
Hashimoto Disease, Obesity Trial in Bialystok (Individually balanced elimination/reducing diets, Individually balanced reducing
Completed
- Hashimoto Disease
- Obesity
- Individually balanced elimination/reducing diets
- Individually balanced reducing diets (without elimination)
-
Bialystok, PolandDepartment of Dietetic and Clinical Nutrition; Medical Universit
Feb 12, 2021
PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on
Recruiting
- Hepatocellular Carcinoma
- Acute Rejection
-
Beijing, Beijing, ChinaBeijing Tsinghua Changgung Hospital
Jun 6, 2022
Drug Use, HCV Infection Trial in Montpellier (HCV screening, Diagnosis of hepatitis C, HCV treatment)
Active, not recruiting
- Drug Use
- HCV Infection
- HCV screening
- +2 more
-
Montpellier, FranceCHU Montpellier
Sep 17, 2021
High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian
Completed
- Covid19
- +3 more
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Painful Osteoarthritis of the Knee Trial in Worldwide (MEDI7352, Placebo)
Recruiting
- Painful Osteoarthritis of the Knee
- MEDI7352
- Placebo
-
Montclair, California
- +92 more
Aug 24, 2022
Infertility, Female Trial in United States (Follitropin delta, Placebo)
Completed
- Infertility, Female
- Follitropin delta
- Placebo
-
Tempe, Arizona
- +23 more
Nov 16, 2021
Infertility Trial in United States (Follitropin delta, Placebo)
Completed
- Infertility
- Follitropin delta
- Placebo
-
Tempe, Arizona
- +22 more
Oct 20, 2021
Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma Trial in United States (drug, biological, other)
Completed
- Extensive Stage Small Cell Lung Carcinoma
- Recurrent Small Cell Lung Carcinoma
- Cisplatin
- +4 more
-
Scottsdale, Arizona
- +300 more
Dec 10, 2020
Smoking, Immune Cell Profiles, Epigenetics and COVID-19
Recruiting
- COVID-19
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Apr 7, 2022
COVID-19 and Multiple Sclerosis Disease Modifying Therapies
Enrolling by invitation
- Covid19
- Multiple Sclerosis
-
Nottingham, Nottinghamshire, United KingdomNottingham University Hospitals NHS Trust
Apr 27, 2021
Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- (no location specified)
Dec 20, 2022
Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)
Recruiting
- Leukemia
- +2 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 13, 2021
Leber's Hereditary Optic Neuropathy (LHON) Trial in Beijing (NR082 injection, Sham Injection)
Recruiting
- Leber's Hereditary Optic Neuropathy (LHON)
- NR082 injection
- Sham Injection
-
Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Dec 21, 2021